1. Home
  2. JOUT vs RLMD Comparison

JOUT vs RLMD Comparison

Compare JOUT & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JOUT

Johnson Outdoors Inc.

HOLD

Current Price

$46.91

Market Cap

456.3M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$5.31

Market Cap

524.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOUT
RLMD
Founded
1970
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.3M
524.9M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
JOUT
RLMD
Price
$46.91
$5.31
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.40
AVG Volume (30 Days)
33.6K
1.6M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
2.53%
N/A
EPS Growth
N/A
45.28
EPS
N/A
N/A
Revenue
$592,415,000.00
$13,070.00
Revenue This Year
$11.67
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
154.83
52 Week Low
$34.69
$0.55
52 Week High
$53.54
$8.00

Technical Indicators

Market Signals
Indicator
JOUT
RLMD
Relative Strength Index (RSI) 51.27 35.17
Support Level $43.00 $4.85
Resistance Level $48.02 $7.28
Average True Range (ATR) 1.31 0.39
MACD 0.14 -0.01
Stochastic Oscillator 49.28 13.01

Price Performance

Historical Comparison
JOUT
RLMD

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: